Clinical Profile and Prognosis of Patients With Acute Decompensated Heart Failure Who Met the Obesity-Related Eligibility for Subcutaneous Semaglutide ― Findings From the CURE-HF Registry ―
Almost 7.2% of the ADHF patients were semaglutide-eligible. Our findings did not affirm the "obesity paradox" in semaglutide-eligible HF patients after adjusting for demographic factors.
Authors
- Yasutaka Oguchi
- Soichiro Ebisawa (ORCID: https://orcid.org/0000-0002-6146-9959)
- Tatsuya Saigusa (ORCID: https://orcid.org/0000-0002-1856-1047)
- Sho Suzuki (ORCID: https://orcid.org/0000-0001-9058-9258)
- Koichiro Kuwahara (ORCID: https://orcid.org/0000-0003-2670-7170)
- Koji Yoshie (ORCID: https://orcid.org/0000-0002-2378-2768)
- Tamon Kato (ORCID: https://orcid.org/0000-0001-5350-4083)
- Yukari Okuma
- Kazuhiro Kimura (ORCID: https://orcid.org/0000-0002-2502-6149)
- Ayako Okada (ORCID: https://orcid.org/0000-0002-8342-1163)
- Hirohiko Motoki (ORCID: https://orcid.org/0000-0002-5219-6856)
- Ken Nishikawa (ORCID: https://orcid.org/0000-0001-9585-1171)
- Kiu Tanaka
- Yasushi Ueki (ORCID: https://orcid.org/0000-0003-4630-9815)
- Masatoshi Minamisawa
Institutions
- Shinshu University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1253/circrep.cr-25-0041
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00